POTENTIAL TARGETS FROM HUMAN (RESULTS FROM SUB-STRUCTURAL SIMILARITY SEARCHES)
1) User may click on the DrReposER ID (the second column) to get information on the binding sites and drug molecule.
2) Click View (the second last column) to view matched residues and superposition in the NGL viewer (upper right part).
3) User may also click on the Dock (the last column) to get script for molecular docking in UCSF Chimera through AutoDock Vina.


DrReposER ID / Desc. Hit
PDBID
Hit
Macromolecule
Res.
Matches
Interface HETATM RMSD Seq.
Identity (%)
View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3LTW_A_HLZA300_1
(ARYLAMINE
N-ACETYLTRANSFERASE
NAT)
1bkd SON OF SEVENLESS-1
(Homo
sapiens)
4 / 6PHE S 634
TYR S 631
CYH S 635
PHE S 627
None
0.91A19.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3LTW_A_HLZA300_1
(ARYLAMINE
N-ACETYLTRANSFERASE
NAT)
1lyw CATHEPSIN D
(Homo
sapiens)
4 / 6PHE B 325
TYR B 283
VAL B 208
PHE B 342
None
1.01A22.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3LTW_A_HLZA300_1
(ARYLAMINE
N-ACETYLTRANSFERASE
NAT)
1q1q SULFOTRANSFERASE
FAMILY, CYTOSOLIC,
2B, MEMBER 1 ISOFORM
A
(Homo
sapiens)
4 / 6PHE A 175
TYR A 282
VAL A 137
PHE A 278
None
1.33A21.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3LTW_A_HLZA300_1
(ARYLAMINE
N-ACETYLTRANSFERASE
NAT)
1q20 SULFOTRANSFERASE
FAMILY, CYTOSOLIC,
2B, MEMBER 1 ISOFORM
B
(Homo
sapiens)
4 / 6PHE A 190
TYR A 297
VAL A 152
PHE A 293
None
1.34A21.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3LTW_A_HLZA300_1
(ARYLAMINE
N-ACETYLTRANSFERASE
NAT)
1xdv SON OF SEVENLESS
PROTEIN HOMOLOG 1
(Homo
sapiens)
4 / 6PHE A 634
TYR A 631
CYH A 635
PHE A 627
None
0.91A17.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3LTW_A_HLZA300_1
(ARYLAMINE
N-ACETYLTRANSFERASE
NAT)
2a1x PHYTANOYL-COA
DIOXYGENASE
(Homo
sapiens)
4 / 6PHE A 124
TYR A 133
CYH A 280
VAL A 331
None
1.38A22.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3LTW_A_HLZA300_1
(ARYLAMINE
N-ACETYLTRANSFERASE
NAT)
2ija ARYLAMINE
N-ACETYLTRANSFERASE
1
(Homo
sapiens)
4 / 6PHE A  37
CYH A  68
VAL A  93
PHE A 217
None
ACM  A 301 (-1.7A)
None
ACM  A 301 (-4.2A)
0.70A29.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3LTW_A_HLZA300_1
(ARYLAMINE
N-ACETYLTRANSFERASE
NAT)
2q6z UROPORPHYRINOGEN
DECARBOXYLASE
(Homo
sapiens)
4 / 6PHE A  84
CYH A  65
VAL A  89
PHE A  55
None
1.35A23.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3LTW_A_HLZA300_1
(ARYLAMINE
N-ACETYLTRANSFERASE
NAT)
3cxp GLUCOSAMINE
6-PHOSPHATE
N-ACETYLTRANSFERASE
(Homo
sapiens)
4 / 6PHE A 168
TYR A 165
VAL A 124
PHE A 164
None
1.33A21.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3LTW_A_HLZA300_1
(ARYLAMINE
N-ACETYLTRANSFERASE
NAT)
3ii7 KELCH-LIKE PROTEIN 7
(Homo
sapiens)
4 / 6TYR A 385
CYH A 378
VAL A 434
PHE A 400
None
1.31A20.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3LTW_A_HLZA300_1
(ARYLAMINE
N-ACETYLTRANSFERASE
NAT)
4bmb GALECTIN-8
(Homo
sapiens)
4 / 6PHE A  46
VAL A 116
THR A 123
PHE A  97
None
1.36A20.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3LTW_A_HLZA300_1
(ARYLAMINE
N-ACETYLTRANSFERASE
NAT)
4fqz GALECTIN-8
(Homo
sapiens)
4 / 6PHE A  46
VAL A 116
THR A 123
PHE A  97
None
1.33A22.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3LTW_A_HLZA300_1
(ARYLAMINE
N-ACETYLTRANSFERASE
NAT)
4p5k RAS PEPTIDE,HLA
CLASS II
HISTOCOMPATIBILITY
ANTIGEN, DP BETA 1
CHAIN
(Homo
sapiens)
4 / 6PHE B  35
TYR B  28
THR B -16
PHE B   9
None
1.12A22.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3LTW_A_HLZA300_1
(ARYLAMINE
N-ACETYLTRANSFERASE
NAT)
4xt1 FRACTALKINE
G-PROTEIN COUPLED
RECEPTOR HOMOLOG
US28
(Cytomegalovirus;
Homo
sapiens)
4 / 6PHE A  82
VAL B   5
THR A  36
PHE A 281
None
1.17A20.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3LTW_A_HLZA300_1
(ARYLAMINE
N-ACETYLTRANSFERASE
NAT)
4zzh NAD-DEPENDENT
PROTEIN DEACETYLASE
SIRTUIN-1
(Homo
sapiens)
4 / 6PHE A 652
TYR A 642
VAL A 476
THR A 242
None
1.24A23.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3LTW_A_HLZA300_1
(ARYLAMINE
N-ACETYLTRANSFERASE
NAT)
5c7m E3 UBIQUITIN-PROTEIN
LIGASE ITCHY HOMOLOG
(Homo
sapiens)
4 / 6PHE A 757
VAL A 604
THR A 657
PHE A 659
None
1.35A21.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3LTW_A_HLZA300_1
(ARYLAMINE
N-ACETYLTRANSFERASE
NAT)
5gzg GALECTIN-8
(Homo
sapiens)
4 / 6PHE A  46
VAL A 116
THR A 123
PHE A  97
None
1.36A20.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3LTW_A_HLZA300_1
(ARYLAMINE
N-ACETYLTRANSFERASE
NAT)
5mc5 XAA-PRO DIPEPTIDASE
(Homo
sapiens)
4 / 6PHE A 284
CYH A 283
THR A  78
PHE A  23
None
1.22A17.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3LTW_A_HLZA300_1
(ARYLAMINE
N-ACETYLTRANSFERASE
NAT)
5v9p LYSINE-SPECIFIC
DEMETHYLASE 5A
(Homo
sapiens)
4 / 6PHE A  70
TYR A 361
VAL A 407
PHE A 366
None
1.38A16.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3LTW_A_HLZA302_1
(ARYLAMINE
N-ACETYLTRANSFERASE
NAT)
1x9d ENDOPLASMIC
RETICULUM
MANNOSYL-OLIGOSACCHA
RIDE
1,2-ALPHA-MANNOSIDAS
E
(Homo
sapiens)
4 / 6LEU A 595
GLU A 570
ARG A 597
HIS A 524
None
None
SMD  A1003 (-3.8A)
None
1.37A19.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3LTW_A_HLZA302_1
(ARYLAMINE
N-ACETYLTRANSFERASE
NAT)
1yb5 QUINONE
OXIDOREDUCTASE
(Homo
sapiens)
4 / 6LEU A 305
GLU A 306
PRO A 304
ARG A   9
None
1.19A22.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3LTW_A_HLZA302_1
(ARYLAMINE
N-ACETYLTRANSFERASE
NAT)
2c11 MEMBRANE COPPER
AMINE OXIDASE
(Homo
sapiens)
4 / 6LEU A  63
GLU A  67
PRO A 147
HIS A 414
None
None
None
CU  A1743 (-3.3A)
1.48A17.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3LTW_A_HLZA302_1
(ARYLAMINE
N-ACETYLTRANSFERASE
NAT)
2g1l KINESIN-LIKE PROTEIN
KIF1C
(Homo
sapiens)
4 / 6LEU A 545
GLU A 561
PRO A 562
ARG A 547
None
1.40A16.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3LTW_A_HLZA302_1
(ARYLAMINE
N-ACETYLTRANSFERASE
NAT)
2mxy HETEROGENEOUS
NUCLEAR
RIBONUCLEOPROTEINS
C1/C2
(Homo
sapiens)
4 / 6LEU A  84
GLU A  87
PRO A  88
ARG A  64
None
None
U  B   4 ( 3.4A)
None
1.47A18.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3LTW_A_HLZA302_1
(ARYLAMINE
N-ACETYLTRANSFERASE
NAT)
3fy7 CHLORIDE
INTRACELLULAR
CHANNEL PROTEIN 3
(Homo
sapiens)
4 / 6LEU A 156
GLU A 153
PRO A 154
ARG A 160
None
1.34A23.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3LTW_A_HLZA302_1
(ARYLAMINE
N-ACETYLTRANSFERASE
NAT)
4a14 KINESIN-LIKE PROTEIN
KIF7
(Homo
sapiens)
4 / 6LEU A  41
GLU A  38
PRO A  39
HIS A  51
None
1.50A22.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3LTW_A_HLZA302_1
(ARYLAMINE
N-ACETYLTRANSFERASE
NAT)
4e54 DNA DAMAGE-BINDING
PROTEIN 2
(Homo
sapiens)
4 / 6GLU B 311
PRO B 328
ARG B 288
HIS B 289
None
1.46A20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3LTW_A_HLZA302_1
(ARYLAMINE
N-ACETYLTRANSFERASE
NAT)
4jnc BIFUNCTIONAL EPOXIDE
HYDROLASE 2
(Homo
sapiens)
4 / 6LEU A 514
GLU A 508
PRO A 512
ARG A 516
None
1.41A21.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3LTW_A_HLZA302_1
(ARYLAMINE
N-ACETYLTRANSFERASE
NAT)
4s0h HOMEOBOX PROTEIN
NKX-2.5
(Homo
sapiens)
4 / 6LEU B 163
GLU B 167
PRO B 166
ARG B 156
None
1.39A13.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3LTW_A_HLZA302_1
(ARYLAMINE
N-ACETYLTRANSFERASE
NAT)
4u0q BASIGIN
(Homo
sapiens)
4 / 6LEU B  90
GLU B  92
PRO B  93
ARG B  54
None
1.43A23.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3LTW_A_HLZA302_1
(ARYLAMINE
N-ACETYLTRANSFERASE
NAT)
4zrq TRANSCOBALAMIN-2
(Homo
sapiens)
4 / 6LEU A 162
GLU A 166
PRO A 167
ARG A 200
None
1.48A22.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3LTW_A_HLZA302_1
(ARYLAMINE
N-ACETYLTRANSFERASE
NAT)
5ajz 6-PHOSPHOFRUCTO-2-KI
NASE/FRUCTOSE-2,6-BI
SPHOSPHATASE 3
(Homo
sapiens)
4 / 6LEU A 346
GLU A 342
PRO A 341
ARG A   8
None
1.33A19.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3LTW_A_HLZA302_1
(ARYLAMINE
N-ACETYLTRANSFERASE
NAT)
5all SOLUBLE EPOXIDE
HYDROLASE
(Homo
sapiens)
4 / 6LEU A 514
GLU A 508
PRO A 512
ARG A 516
None
1.42A19.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3LTW_A_HLZA302_1
(ARYLAMINE
N-ACETYLTRANSFERASE
NAT)
5c4g PHOSPHATIDYLINOSITOL
4-KINASE BETA
(Homo
sapiens)
4 / 6LEU E 518
GLU E 520
PRO E 521
ARG E 528
None
1.37A19.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3LTW_A_HLZA302_1
(ARYLAMINE
N-ACETYLTRANSFERASE
NAT)
5gwn PROTEIN RCC2
(Homo
sapiens)
4 / 6LEU A 132
GLU A 191
PRO A 519
ARG A 189
None
1.34A22.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3LTW_A_HLZA302_1
(ARYLAMINE
N-ACETYLTRANSFERASE
NAT)
5una 7SK SNRNA
METHYLPHOSPHATE
CAPPING ENZYME
(Homo
sapiens)
4 / 6LEU A 581
GLU A 616
PRO A 617
ARG A 433
SAH  A 701 (-4.4A)
SAH  A 701 ( 4.9A)
None
SAH  A 701 (-3.1A)
1.15A21.02